Fymskina
Information on Fymskina®for Patients and Healthcare Professionals
Fymskina® Drug Leaflet
Please select the Presentation and Dosage
Instructions for use:Information for Patients(available in German only)
Fymskina®45 mgSolution for Injection in a Pre-filled Syringe
Instructions for use:Information for Patients(available in German only)
Fymskina®90 mgSolution for Injection in a Pre-filled Syringe
Instructions for use:Information for Patients(available in German only)
Fymskina®130 mgConcentrate for preparing an Infusion Solution
Fymskina® Summary of Product Characteristics
Please select the Presentation and Dosage
ReportingAdverse Reactions
If you notice any adverse reactions, please contact your doctor or pharmacist. This also applies to adverse reactions not listed in the drug leaflet. You can also report adverse reactions directly to the Federal Institute for Vaccines and Biomedical Medicines,
Paul Ehrlich Institute
(Paul-Ehrlich-Straße 51 – 59, 63225 Langen,
Phone: +49 6 10 37 70, Fax: +49 61 03 77 12 34,
Website: www.pei.de).
By reporting adverse reactions, you can help to provide more information about the safety of this medicine.
This medicine is being closely monitored. This allows new findings about safety to be identified quickly. You can help by reporting any adverse reactions you experience.
The Paul Ehrlich Institute provides an online form for reporting adverse reactions:
Additionally, you can report adverse reactions of Fymskina® via email to Formycon AG. When reporting, please be sure to include the name of the medicine and the batch number. The batch number (CH.-B.) is a combination of letters and numbers that can be found on the medicine packaging along with the serial number and expiration date.
medinfo@formycon.com
Please read our information on
Data Protection.
